Pharmaceutical Commerce


Pharmaceutical Commerce - September/October 2012

Solving the payer's problem: a new key to market access

August 30, 2012

Understand when total cost of care is the only winning argument - and when you can ignore it, says Oliver Wyman

Express Scripts and Walgreens settle, but now 'narrow networks' are in play

August 30, 2012

Implications for pharma are in continuing pricing pressure, and preferences for distribution channels

Owens & Minor plans to acquire Movianto Group, a European healthcare 3PL

August 30, 2012

Action adds to the increasing number of global healthcare-distribution pathways

Grappling with the long-term care market

August 30, 2012

The geriatric-dominated LTC market is growing, but has unique constraints

How cloud services accelerate market analytics

August 30, 2012

Deployment of Model N cloud-based IT services boosts internal capabilities at J&J

Making the EHR/e-prescribing/drug-label connection

August 30, 2012

Achieving a 'clinical workflow' compatible with doctors' and hospital administrators' online preferences is the goal; will pharma promotional messaging find a place?

Container selection and testing for safe drug product delivery

August 30, 2012

Elaborate testing is necessary to ensure the stability and functionality of today's drug-delivery systems

A conversation with Mike Alkire, Premier, Inc.

August 29, 2012

Premier, one of the leading group purchasing organizations (GPOs), is a vital linkage point between nearly 90,000 healthcare sites in the US, and the drug, device and hospital-supply vendors that serve them. Pharmaceutical Commerce sat down with Mike Alkire, chief operating officer of the company, to hear about what's driving GPO evolution today, and how it interacts with pharma manufacturers. Here's what he had to say:

Coordinating payer contracts and direct-to-patient discounting

August 29, 2012

Although controversial, patient-focused discounts can play a valuable role in managed-markets programs

Complex supply chains demand a holistic approach to protect patients

August 29, 2012

The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity

Tectonic shifts in the product-security debate

August 29, 2012

Industry is not waiting for action in Washington

Ensuring the quality of comparative effectiveness research

August 28, 2012

As payers seek higher-quality data from real-world treatment settings, the importance of reliable measures becomes critical

Integrated drug containment and delivery solutions

August 28, 2012

Design choices can make a difference in a crowded market

Building bridges to rare disease patients

August 28, 2012

Orphan drug development and marketing have important distinct requirements for R&D, regulatory and marketing

2012 Product Security Report

August 27, 2012

Serialization systems are going into operation around the world, but cross-industry collaboration awaits new legislation